Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.

about

Current Controversies in the Management of Myeloma Bone Disease.Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis.Bisphosphonates in multiple myeloma: an updated network meta-analysis.

P2860

Q38748577-D2F6EFB3-3665-40D9-9E10-4053242B2FAD Q46115937-72E2E29A-D94A-4E74-B15C-9D2E64851732 Q47290135-3A7B6B9F-01ED-4790-A510-8A47E4FD4628

P2860

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.

Item

http://www.wikidata.org/entity/Q36708998

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@ast

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@en

type

Item

label

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@ast

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@en

prefLabel

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@ast

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@en

P1476

Zoledronic acid as compared wi ...... omized AZABACHE Spanish trial.

@en

P2093

Ana I Teruel

http://www.w3.org/2001/XMLSchema#string

Angel R Payer

http://www.w3.org/2001/XMLSchema#string

Eugenia Abellá

http://www.w3.org/2001/XMLSchema#string

Joan Bargay

http://www.w3.org/2001/XMLSchema#string

Luis Palomera

http://www.w3.org/2001/XMLSchema#string

María J Blanchard

http://www.w3.org/2001/XMLSchema#string

María J Moreno

http://www.w3.org/2001/XMLSchema#string

María V Mateos

http://www.w3.org/2001/XMLSchema#string

Miguel T Hernández

http://www.w3.org/2001/XMLSchema#string

Miquel Granell

http://www.w3.org/2001/XMLSchema#string

P2860

Introduction: the evolving role of bisphosphonate therapy in multiple myeloma.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

International uniform response criteria for multiple myeloma.

Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation.

Effect of pathologic fractures on survival in multiple myeloma patients: a case control study

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

Costs of multiple myeloma and associated skeletal-related events in The Netherlands.

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

P304

1207-1213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2015.128439

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278039457

http://www.w3.org/2001/XMLSchema#string

P698

26069291

http://www.w3.org/2001/XMLSchema#string

P932

4800701

http://www.w3.org/2001/XMLSchema#string

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.

about

P2860

P2860

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932